| Market Cap | ₹103Cr |
| ROE | -0.57% |
| P/E Ratio(TTM) | -264.00 |
| EPS(TTM) | -0.03 |
| P/B Ratio | 1.53 |
| Dividend Yield | 0.00% |
| Industry P/E | 40.22 |
| Book Value | 5.16 |
| Debt to Equity | 0.23 |
| Face Value | 2 |
| Parent Organisation | Vaishali Pharma Limited |
| Managing Director | Mr. Atul Vasani |
| NSE Symbol | VAISHALI |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.25 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.30 | ||
| Wockhardt | NA (0.00%) | -427.29 | ||
| Cohance Lifesciences | NA (0.00%) | 65.51 |